Bio Green Med Solution, Inc. — Director's Dealing 2010

Jan 11, 2010

SEC Form 3/A — Form 3/A

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2009-07-24

Reporting Person: MARXE AUSTIN W & GREENHOUSE DAVID M (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3647058	Indirect

Footnotes

F1: This is a joint filing by Austin W. Marxe (Marxe) and David M. Greenhouse (Greenhouse). They share voting and investment control over all securities owned by Special Situations Fund III QP, L.P. (QP), Special Situations Private Equity Fund, L.P. (PE) and Special Situations Life Sciences Fund, L.P. (LS), respectively. 2,352,942 shares of Common Stock are held by QP, 588,235 shares of Common Stock are held by PE and 705,881 shares of Common Stock are held by LS. The interest of Marxe and Greenhouse in the shares of Common Stock owned by QP, PE and LS is limited to the extent of his pecuniary interest.